GSK was trying to revive a product pulled from US markets in 2022. Its shares fell 4.6 per cent, or 65p, to 1348p.Read More

You might also be interested in reading BTCC Exchange Crosses 10 Million Users: Head of Operations Alex Hung on Building for the Long Term.